











915
Jaeger-LeCoultre
Ref. 201
Reverso
A very rare, early and important stainless steel reversible double-signed wristwatch with black dial, engraved caseback, made for The World Disarmament Conference, retailed by Golay Fils & Stahl
Full-Cataloguing
In addition to the initials engraved on the present watch, the caseback is also engraved “Conférence Désarmement Genève 1932”. The World Disarmament Conference was an international conference of states held in Geneva between February 1932 and November 1934 to accomplish disarmament in accordance with the Covenant of the League of Nations. It was attended by 61 states, most of which were members of the League of Nations, but the USSR and the United States also attended. It is speculated that the present example could have been specially commissioned and made for an important attendee of the Conference.
This highly collectible and early Reverso with a rich history is further accompanied by an Extract from the Archives confirming the production of the present timepiece circa 1931.
Jaeger-LeCoultre
Swiss | 1833Not all companies in the watchmaking field have been able to stand the test of time quite like Jaeger LeCoultre, also known as the "watchmaker's watchmaker." Founded in 1833 by Antoine LeCoultre and originally named LeCoutre, the firm provided watchmaking's top brands, such as Patek Philippe, Vacheron Constantin and Audemars Piguet, the high-grade, unfinished mechanical movements with which they completed their watches.
In the early 1900s, Cartier's watch supplier Edmond Jaeger sought out LeCoultre's help in creating the world's thinnest watches. The collaboration resulted in the creation of Cartier's earliest Tank and Santos watches, all housed with LeCoultre movements. The duo decided to merge in 1937, and the firm officially became the Jaeger-LeCoultre brand by which collectors know and adore it today. Some of the firm's most significant and important timepieces include the Reverso, the Memovox, the Atmos clock and, among modern watches, their Master Complications.